Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies

Fast, accurate and reliable methods to quantify the amount of myelin still lack, both in humans and experimental models. The overall objective of the present study was to demonstrate that sphingomyelin (SM) in the cerebrospinal fluid (CSF) of patients affected by demyelinating neuropathies is a myel...

Descripción completa

Detalles Bibliográficos
Autores principales: Capodivento, Giovanna, Visigalli, Davide, Garnero, Martina, Fancellu, Roberto, Ferrara, Michela Demetra, Basit, Abdul, Hamid, Zeeshan, Pastore, Vito Paolo, Garibaldi, Silvano, Armirotti, Andrea, Mancardi, Gianluigi, Serrati, Carlo, Capello, Elisabetta, Schenone, Angelo, Nobbio, Lucilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552737/
https://www.ncbi.nlm.nih.gov/pubmed/28798317
http://dx.doi.org/10.1038/s41598-017-08314-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552737/
https://www.ncbi.nlm.nih.gov/pubmed/28798317
http://dx.doi.org/10.1038/s41598-017-08314-1

Ejemplares similares